These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia. Scott LJ Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272 [TBL] [Abstract][Full Text] [Related]
25. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561 [TBL] [Abstract][Full Text] [Related]
26. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels. Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692 [TBL] [Abstract][Full Text] [Related]
27. Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms. Fujisawa Y; Kitaoka T; Ono H; Nakashima S; Ozono K; Ogata T Front Endocrinol (Lausanne); 2020; 11():590455. PubMed ID: 33391183 [TBL] [Abstract][Full Text] [Related]
28. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates. Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187 [TBL] [Abstract][Full Text] [Related]
29. A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the Hacıhamdioğlu B; Özgürhan G; Pereira C; Tepeli E; Acar G; Cömert S J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):306-310. PubMed ID: 30468149 [TBL] [Abstract][Full Text] [Related]
30. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Schmidt T; Mussawy H; Rolvien T; Hawellek T; Hubert J; Rüther W; Amling M; Barvencik F Osteoporos Int; 2017 Sep; 28(9):2653-2662. PubMed ID: 28547134 [TBL] [Abstract][Full Text] [Related]
31. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges. Whyte MP J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648 [TBL] [Abstract][Full Text] [Related]
32. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health. Lin EL; Gottesman GS; McAlister WH; Bijanki VN; Mack KE; Griffin DM; Mumm S; Whyte MP Bone; 2020 Jul; 136():115322. PubMed ID: 32200022 [TBL] [Abstract][Full Text] [Related]
33. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia. Hofmann C; Seefried L; Jakob F Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160 [TBL] [Abstract][Full Text] [Related]